Pharmacology and Toxicology Department Highlights: February 2022

(February 1, 2022)


Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (ROCK) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery. Pharmaceutics: Special Issue on Medical Aerosol Drug Delivery (2021) 13 (12): 2188. PMID: 34959469.


Wei Wang, PhD was invited to give two talks "Organocatalyzed Formylation Reactions" in the symposium "Development of New Reactions and Technologies Adaptable to Process Chemistry" and "Organocatalyzed practical synthesis of deuterated aldehydes and amino acids" in the symposium "New Aspects on Organocatalysts" in virtual 2021 PacificChem on December 16-21, 2021

Wei Wang, PhD post-doc Feng Gao has been awarded the 2022 Postdoctoral Fellowship in Drug Discovery entitled “Discovery of PROTAC degraders of the SARS-Cov-2 main protease for the treatment of Covid-19" by the Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation).

Jianqin Lu, PhD was awarded the 2022 PhRMA Foundation Research Starter Grant in Drug Delivery ($100,000 for one year).